West Pharmaceutical Services, Inc.

BOVESPA:W2ST34 Stock Report

Market Cap: R$146.0b

West Pharmaceutical Services Management

Management criteria checks 3/4

West Pharmaceutical Services' CEO is Eric Green, appointed in Apr 2015, has a tenure of 9.67 years. total yearly compensation is $9.40M, comprised of 12.1% salary and 87.9% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth R$338.56M. The average tenure of the management team and the board of directors is 4.5 years and 8.9 years respectively.

Key information

Eric Green

Chief executive officer

US$9.4m

Total compensation

CEO salary percentage12.1%
CEO tenure9.7yrs
CEO ownership0.2%
Management average tenure4.5yrs
Board average tenure8.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Eric Green's remuneration changed compared to West Pharmaceutical Services's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$500m

Jun 30 2024n/an/a

US$525m

Mar 31 2024n/an/a

US$569m

Dec 31 2023US$9mUS$1m

US$593m

Sep 30 2023n/an/a

US$559m

Jun 30 2023n/an/a

US$519m

Mar 31 2023n/an/a

US$552m

Dec 31 2022US$8mUS$1m

US$586m

Sep 30 2022n/an/a

US$631m

Jun 30 2022n/an/a

US$686m

Mar 31 2022n/an/a

US$684m

Dec 31 2021US$9mUS$1m

US$662m

Sep 30 2021n/an/a

US$613m

Jun 30 2021n/an/a

US$519m

Mar 31 2021n/an/a

US$423m

Dec 31 2020US$8mUS$989k

US$346m

Sep 30 2020n/an/a

US$312m

Jun 30 2020n/an/a

US$286m

Mar 31 2020n/an/a

US$261m

Dec 31 2019US$7mUS$936k

US$242m

Sep 30 2019n/an/a

US$230m

Jun 30 2019n/an/a

US$229m

Mar 31 2019n/an/a

US$219m

Dec 31 2018US$5mUS$880k

US$207m

Sep 30 2018n/an/a

US$155m

Jun 30 2018n/an/a

US$151m

Mar 31 2018n/an/a

US$133m

Dec 31 2017US$5mUS$824k

US$151m

Compensation vs Market: Eric's total compensation ($USD9.40M) is above average for companies of similar size in the BR market ($USD5.71M).

Compensation vs Earnings: Eric's compensation has been consistent with company performance over the past year.

CEO

Eric Green (54 yo)

9.7yrs

Tenure

US$9,395,896

Compensation

Mr. Eric M. Green serves as Independent Director at Ecolab Inc. since December 08, 2022. He has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 24, 2015 and its President...

Leadership Team

NamePositionTenureCompensationOwnership
Eric Green
Non-Independent Chair of the Board9.7yrsUS$9.40m0.23%
R$ 338.6m
Bernard Birkett
Senior VP & CFO6.5yrsUS$3.64m0.0095%
R$ 13.9m
Silji Abraham
Senior VP & CTO4yrsUS$1.67m0.0043%
R$ 6.3m
Kimberly MacKay
Senior VP4yrsUS$1.49m0.0019%
R$ 2.7m
Cindy Reiss-Clark
Senior VP & Chief Commercial Officer5.1yrsUS$1.53m0.0067%
R$ 9.9m
Chad Winters
VP, Chief Accounting Officer & Corporate Controller5.2yrsno data0.0018%
R$ 2.6m
John Sweeney
Head of Investor Relationsno datano datano data
Michele Polinsky
Vice President of Global Communicationsno datano datano data
Rudy Poussot
Senior VP of Strategy & Corporate Development1.1yrsno datano data
Annette Favorite
Chief Human Resources Officer & Senior VP9.2yrsUS$1.14m0.0090%
R$ 13.1m
Kathy DePadua
Senior VP and Chief Quality & Regulatory Officer2.6yrsno datano data
Aileen Ruff-Patry
President of Contract Manufacturingless than a yearno datano data

4.5yrs

Average Tenure

54yo

Average Age

Experienced Management: W2ST34's management team is considered experienced (4.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Eric Green
Non-Independent Chair of the Board9.6yrsUS$9.40m0.23%
R$ 338.6m
Myla Lai-Goldman
Independent Director10.8yrsUS$359.35k0.024%
R$ 34.6m
Robert Friel
Independent Director4.8yrsUS$330.66k0.0034%
R$ 4.9m
Thomas Hofmann
Independent Director17.2yrsUS$390.35k0.059%
R$ 86.7m
Janet Haugen
Directorno datano data0.00059%
R$ 861.6k
Mark Buthman
Independent Director13.8yrsUS$378.23k0.056%
R$ 81.9m
Douglas Michels
Independent Director13.8yrsUS$377.01k0.059%
R$ 86.5m
Paolo Pucci
Lead Independent Director8.3yrsUS$367.44k0.012%
R$ 17.5m
Stephen Lockhart
Independent Director2.4yrsUS$331.46k0.0015%
R$ 2.2m
William Feehery
Independent Director12.8yrsUS$362.83k0.040%
R$ 58.7m
Deborah L. Keller
Independent Director7.5yrsUS$333.45kno data
Molly Joseph
Independent Director3.3yrsUS$321.43k0.00087%
R$ 1.3m

8.9yrs

Average Tenure

64yo

Average Age

Experienced Board: W2ST34's board of directors are considered experienced (8.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

West Pharmaceutical Services, Inc. is covered by 28 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Lawrence MarshBarclays
Michael RyskinBofA Global Research